Corrigendum to "Use of the nonavalent HPV vaccine in individuals previously fully or partially vaccinated with bivalent or quadrivalent HPV vaccines" [Vaccine 34 (2016) 757-761].

Van Damme, Pierre; Bonanni, Paolo; Bosch, F Xavier; Joura, Elmar; Kjaer, Susanne Krüger; Meijer, Chris J L M; Petry, Karl-Ulrich; Soubeyrand, Benoit; Verstraeten, Thomas; Stanley, Margaret

Van Damme, Pierre; Bonanni, Paolo; Bosch, F Xavier; Joura, Elmar; Kjaer, Susanne Krüger; Meijer, Chris J L M; Petry, Karl-Ulrich; Soubeyrand, Benoit; Verstraeten, Thomas; Stanley, Margaret.

Afiliación

Van Damme P; Centre for Evaluation of Vaccination, Vaccine and Infectious Diseases Institute, University of Antwerp, Antwerp, Belgium. Electronic address: pierre.vandamme@uantwerp.be.
Bonanni P; Department of Health Sciences, University of Florence, Florence, Italy.
Bosch FX; Cancer Research Epidemiology Program, Catalan Institute of Oncology, IDIBELL, Barcelona, Spain.
Joura E; Department of Obstetrics and Gynecology, Comprehensive Cancer Center Vienna, Medical University of Vienna, Vienna, Austria.
Kjaer SK; Department of Gynaecology, Juliane Marie Centre, Rigshospitalet, Copenhagen University Hospital and the University of Copenhagen, Copenhagen, Denmark.
Meijer CJLM; Department of Pathology, Free University Medical Center, Amsterdam, The Netherlands.
Petry KU; Department of Gynaecology and Obstetrics, Klinikum Wolfsburg, Wolfsburg, Germany.
Soubeyrand B; Sanofi Pasteur MSD, Department of Medical Affairs, Lyon, France.
Verstraeten T; P95, Epidemiology and Pharmacovigilance Consulting and Services, Leuven, Belgium.
Stanley M; Department of Pathology, Cambridge University, Cambridge, UK.

Vaccine ; 34(39): 4759-4760, 2016 09 07.

Article en En | MEDLINE | ID: mdl-27461456

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Vaccine Año: 2016 Tipo del documento: Article